The largest database of trusted experimental protocols

8 protocols using buthionine sulphoximine bso

1

Ex vivo Evaluation of IACS-010759 in PDX

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ex vivo evaluation of cell viability in response to IACS-010759 exposure was performed in HBCx-137 derived cell cultures, following a protocol detailed elsewhere62 (link). Briefly, fresh breast cancer PDX tissues were minced and further dissociated using a digestion medium. This was followed by further dissociation using trypsin (GIBCO), Dispase (StemCell Technologies, 7913) and DNase (Sigma, D4513). Cells were resuspended in MEGM (Lonza, CC-3150) and falcon® 40-μm cell strainers were used to remove the undigested tissue. Single-cell suspensions generated from tumours were plated in triplicates at 40,000 cells/well into 96-well plates. The effect of IACS treatment (0 to 15 µM—48 h), with and without Buthionine sulphoximine (BSO) (Sigma, B2515) at 10 mM, on cell viability was determined by CellTiterGlo assay (Promega, G7571) and drug responses represented by the half-maximal inhibitory concentration (IC50) and the dose-response curve. The experiment was performed in two biological replicates. Cell viability was normalised to DMSO (vehicle) treated cells.
+ Open protocol
+ Expand
2

Establishing GBM and Non-Cancerous Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
GBM cell lines (U87, U251, LN229, DBTRG) and non-cancerous human lung fibroblast cell line (MRC-5) were purchased from ATCC. U87, U251 and MRC-5 were cultured in MEM (Gibco) with 10% fetal bovine serum (FBS) and 2 mM L-glutamine. LN229 was cultured in DMEM (Gibco) with 10% FBS and 2 mM L-glutamine. DBTRG was cultured in RPMI1640 (Gibco) supplemented with 10% FBS, 2 mM L-glutamine, 25 mM HEPES and 1 mM sodium pyruvate. Patient-derived GBM cell line BAH1 was kindly provided by our collaborative researchers at Queensland Institute of Medical Research and was cultured in Advanced DMEM/F12 (Gibco) mixed with NeurobasalTM-A medium (Gibco) (1:1) supplemented with B-27 (1×), FGF (20 ng/mL) and EGF (20 ng/mL). Normal human astrocytes were purchased from Lonza and cultured in Astrocyte Growth Medium with Astrocyte Medium Bullet Kit (Lonza). PENAO was synthesized as previously published [25 (link)]. Sodium dichloroacetate (DCA), N-acetyl-L-cysteine (NAC), glutathione reduced ethyl ester (GSH-MEE) and buthionine sulphoximine (BSO) were purchased from Sigma-Aldrich.
+ Open protocol
+ Expand
3

Investigating PAT Toxicity Mechanisms

Check if the same lab product or an alternative is used in the 5 most similar protocols
Preliminary experiments used toxic exposure (2.5 µM PAT) determined from cytotoxic assays in previous studies using the same model33 (link),34 (link). Concentrations relevant to environmental and safety levels (0.2 µM; 0.5 µM; 1 µM PAT)—determined from incidence, monitor studies and literature were used to validate findings and molecular mechanisms in subsequent assays2 (link),3 (link).
Experiments examining the effects of PAT on ADRA1 protein signalling were exposed to PAT as described above. Cells were preincubated with α1-AR agonist Epi (Sigma, St Louis, USA) 10 µM for 30 min (min) prior to PAT exposure and further incubated for 24 h36 (link). Buthionine Sulphoximine (BSO) 5 mM (Sigma, St Louis, USA) and N-acetylcysteine (NAC) 2 mM were preincubated for 1 h followed by the PAT exposure, to simulate GSH depletion and supplementation, respectively (Supplementary Data S1). This was included to determine whether observed effects were related to previously established mechanisms of PAT toxicity65 (link). Experiments conducted using cells pre-exposed to AMPK activator metformin (5 mM) for 30 min—5 mM concentration was selected from literature66 (link).
+ Open protocol
+ Expand
4

Multimodal Cellular Characterization Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hoechst 33342 (H3570, 1:500), 2′,7′-dichlorodihydrofluorescein diacetate, acetyl ester (CM-H2DCFDA. C6827, 1:1000), ThiolTracker™ violet (T10095, 1:500), Alexa Fluor® 633 Phalloidin (A22284, 1:100), Goat anti-mouse Alexa Fluor® 488 (A11001, 1:500), Goat anti-rabbit Alexa Fluor® 633 (A21070, 1:500), Goat anti-mouse Alexa Fluor® 633 (A21050, 1:500) and Goat anti-rabbit Alexa Fluor® 488 (A11008, 1:500) were purchased from Molecular Probes (Invitrogen). Rabbit monoclonal anti-CD44 (EPR10133Y clone, ab51037, 1:1000) rabbit polyclonal anti-EpCAM (ab71916, 1:1000) and mouse monoclonal anti-CD90 (ab133350, 1:1000) were purchased from Abcam (CSP, Cambridge, England). Methotrexate, Doxorubicin, Cisplatin, Sorafenib, Sulfasalazine (SASP), Buthionine sulphoximine (BSO), Arsenic trioxide, Etoposide and Hydrogen peroxide (H2O2) were purchased from Sigma Chemicals. Mouse monoclonal anti-CD133/1 (AC133, 130-090-422, 1:100) was purchased from Miltenyi biotec (Bergisch Gladbach, Germany). Rabbit polyclonal anti-AFP (Dako, Denmark A/S, Denmark, A000829. 1:500) and mouse monoclonal anti-β-actin (Sigma, A5441, 1:10,000) antibodies were purchased from each of the indicated companies.
+ Open protocol
+ Expand
5

Ferroptosis Modulation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following reagents were used at the indicated concentrations: Concanamycin A (ConA) (Sigma) 100 nM; SYTOX Green Nucleic Acid Stain (S7020; Invitrogen, Carlsbad, CA) 5 nM; Ferrostatin-1 (Fer-1) (EMD Millipore, Billerica, MA) 1 μM; Liproxstatin-1 (Selleckchem) 1 μM and 125 mg/kg for in vitro and in vivo, respectively; Deferoxamine (DFO) (Sigma) 100 μM; Butylated hydroxyanisole (BHA) (Sigma) 50 μM; Ascorbic acid (Asc Acid) (Sigma) 200 μM; Trolox (Sigma) 100 μM; N-acetylcysteine (NAC) (Sigma) 10 mM; Glutathione (GSH) (Sigma) 5 mM; TNFα (Sigma) 100 ng/ml; Cycloheximide (CHX) (Sigma) 1 μg/ml and 50 μg/ml to induce necroptosis and apoptosis, respectively; zVAD (Sigma) 20 μM; Necrostatin-1 (Sigma) 30 μM; Buthionine sulphoximine (BSO) (Sigma) 400 μM; Ferric ammonium citrate (FAC) (Sigma, F5879) 400 μM; Erastin (Sigma), 5 μM, C11-BODIPY(581/591) 2 μM (Invitrogen). Reagents were added to cultures at the start of biological assays with the exception of ConA which was added 1 hour prior to lysis for western blotting.
+ Open protocol
+ Expand
6

Quantifying Intracellular Glutathione Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T cells were cultured in DMEM medium (Thermo Fisher, Waltham, MA, USA) containing 10% heat inactivated fetal bovine serum (FBS) (Thermo Fisher, Waltham, MA, USA), 1% penicillin-streptomycin (Sigma, St. Louis, MO, USA), 1% L-glutamine (Thermo Fisher, Waltham, MA, USA), and 2‰ fungizone (Thermo Fisher, Waltham, MA, USA). Cells were plated at 2.7 × 105 cells/mL density in 8 well ibidi-slide (ibidi, Planegg, Germany). Cell were incubated for 4 h in medium with or without 10 mM buthionine sulphoximine (BSO, Sigma, St. Louis, MO, USA). Cells were incubated for 15 min in PBS containing 50 µM sensor 1, then washed 3 times using warm PBS saline. Plates were exposured under a UV lamp for 10 min to activate 1 prior to imaging. An Olympus FluroView V10i confocal microscope was used for all the imaging. For the imaging of cells treated with GSH sensor, λAbsEm = 559/570–670 nm was used. Same laser intensities and reading sensitivities were used for all imaging sessions. Cell images were processed and the overall fluorescence intensity of each sample was measured using ImageJ Fiji.
+ Open protocol
+ Expand
7

Assessing Lead Tolerance in Arabidopsis

Check if the same lab product or an alternative is used in the 5 most similar protocols

Arabidopsis thaliana seeds of wild-type (WT; Col-0), pse1-1 (SALK_046412; Alonso et al., 2003 (link)), and transgenic plants were surface-sterilized and then germinated on half-strength Murashige and Skoog (1/2 MS) medium containing 1% (w/v) agar and 2% (w/v) sucrose at pH 5.8. The seeds were vernalized at 4 °C for 3 d in the dark. The plants were grown in a controlled culture room at 22 °C under long-day (16h of light/8h of dark) conditions with a light intensity of 100 µmol m−2 s−1.
For the Pb tolerance test, seeds of the WT, the pse1-1 mutant, and the transgenic plants were germinated and grown vertically on 1/2 MS medium in the absence or presence of the indicated concentrations of Pb(NO3)2 or the glutathione synthesis inhibitor, buthioninesulphoximine (BSO; Sigma) for 2 weeks, to check whether Pb tolerance in PSE1-overexpressing plants is glutathione dependent. Then, the plants were weighed and their root lengths were measured. There were triplicate replicates for the Pb tolerance test, and ~30 plants were used for each measurement. For Pb-inducible gene expression analysis, the plants were grown for 2 weeks on 1/2 MS medium and then exposed to a solution of 0.5mM Pb(NO3)2 or water (control) at the designated time points specified in the text.
+ Open protocol
+ Expand
8

Ferroptosis Modulation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following reagents were used at the indicated concentrations: Concanamycin A (ConA) (Sigma) 100 nM; SYTOX Green Nucleic Acid Stain (S7020; Invitrogen, Carlsbad, CA) 5 nM; Ferrostatin-1 (Fer-1) (EMD Millipore, Billerica, MA) 1 μM; Liproxstatin-1 (Selleckchem) 1 μM and 125 mg/kg for in vitro and in vivo, respectively; Deferoxamine (DFO) (Sigma) 100 μM; Butylated hydroxyanisole (BHA) (Sigma) 50 μM; Ascorbic acid (Asc Acid) (Sigma) 200 μM; Trolox (Sigma) 100 μM; N-acetylcysteine (NAC) (Sigma) 10 mM; Glutathione (GSH) (Sigma) 5 mM; TNFα (Sigma) 100 ng/ml; Cycloheximide (CHX) (Sigma) 1 μg/ml and 50 μg/ml to induce necroptosis and apoptosis, respectively; zVAD (Sigma) 20 μM; Necrostatin-1 (Sigma) 30 μM; Buthionine sulphoximine (BSO) (Sigma) 400 μM; Ferric ammonium citrate (FAC) (Sigma, F5879) 400 μM; Erastin (Sigma), 5 μM, C11-BODIPY(581/591) 2 μM (Invitrogen). Reagents were added to cultures at the start of biological assays with the exception of ConA which was added 1 hour prior to lysis for western blotting.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!